Kenyan Health Patient Information Leaflet
Therapeutic agent (verify pharmacological class)
Endometriosis, postponement of men-struation, pre-menstrual syndrome, dysmenorrhoea and menorrhagia. Norethisterone enanthate is used as a contraceptive Clinical selection for Norethisterone contraceptive should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Therapeutic agent (verify pharmacological class). Confirm site-specific dose, duration and monitoring before prescribing.
200mg deep 1.M every 8 weeks for 24 weeks then every 12 weeks.
Hypersensitivity reactions; changes in libido; acne; GI disturbances; weight gain; break-through bleeding; breast changes; mental depression; and fluid retention.
Store as labelled. Keep out of reach of children.